AMCoR Asahikawa Medical College
HOME
|

AMCoR:Asahikawa Medical University Collection and Research (旭川医科大学学術成果リポジトリ)は、本学で生産された電子的な知的生産物(学術雑誌論文の原稿・教材・学術資料など)を保存し、原則的に無償で発信するためのインターネット上の保管庫です。

※AMCoRに収録された学術論文のほとんどは、商業出版社や学会出版社の学術雑誌に掲載されたものですが、著作権に係わる出版社の方針により、出版社の条件に添った版を収録しています。そのため実際の誌面とはレイアウトの相違や、字句校正による文言の違いがあり得ますことをあらかじめご了承ください。


| ホーム ニュース ログイン |

Language

AMCoR検索
  
     詳細検索

インデックスツリー

詳細



閲覧数:1075
ID 22182582
アイテムタイプ Article
このアイテムを表示する
本文 22182582.pdf
Type : application/pdf Download
Size : 1.3 MB
Last updated : Feb 26, 2013
Downloads : 1454

Total downloads since Feb 26, 2013 : 1454
タイトル Oxicam structure in non-steroidal anti-inflammatory drugs is essential to exhibit Akt-mediated neuroprotection against 1-methyl-4-phenyl pyridinium-induced cytotoxicity
著者
田崎, 嘉一 (Tasaki, Yoshikazu)
Yamamoto, Joe
Omura, Tomohiro
Noda, Toshihiro
Kamiyama, Naoya
Yoshida, Koichi
Satomi, Machiko
Sakaguchi, Tomoki
Asari, Masaru
Ohkubo, Tomoko
Shimizu, Keiko
Matsubara, Kazuo
上位タイトル
European journal of pharmacology Vol.676, No.1-3  (2012. 2) ,p.57- 63
識別番号
ISSN
0014-2999
DOI 10.1016/j.ejphar.2011.11.046
抄録 In the treatment of Parkinson's disease, potent disease-modifying drugs are still needed to halt progressive dopaminergic neurodegeneration. We have previously shown that meloxicam, an oxicam non-steroidal anti-inflammatory drug (NSAID), elicits a potent neuroprotective effect against 1-methyl-4-phenyl pyridinium (MPP(+))-induced toxicity in human dopaminergic SH-SY5Y neuroblastoma cells. This cyclooxygenase-independent neuroprotection of meloxicam is mediated via the phosphatidylinositol 3-kinase (PI3K)/Akt pathway; however, the specific chemical structure involved in inducing neuroprotection remains unresolved. In this study, we therefore investigated the structure-specific for eliciting the neuroprotective effect by examining a series of NSAIDs against MPP(+) toxicity in SH-SY5Y cells. Three oxicam-bearing NSAIDs showed potent neuroprotective effects, although none of the other 10 oxicam-nonbearing NSAIDs (3 salicylates, 6 coxibs and 1 polyphenol) or 3 piroxicam analogs (including ampiroxicam, a precursor of piroxicam) exerted any neuroprotection. Tenoxicam and piroxicam prevented MPP(+)-induced reduction of phosphorylated Akt levels in cells: a protective mechanism similar to that of meloxicam. Therefore, the oxicam structure was likely to be responsible for exhibiting the neuroprotection by sustaining survival-signaling in dopaminergic cells. The present results raise the possibility that the oxicam-bearing NSAIDs may serve as potential therapeutic drugs to retard or terminate progression of Parkinson's disease via a novel mechanism.
キーワード
Oxicam
Non-steroidal anti-inflammatory drug
Neuroprotection
Parkinson’s disease
Akt
1-methyl-4-phenyl pyridinium
注記 Author
言語
eng
資源タイプ text
ジャンル Journal Article
著者版フラグ author
Index
/ Public
/ Public / 国外雑誌論文
関連アイテム